Rigidez arterial en sujetos normotensos e hipertensos: frecuencia en farmacias comunitarias

Rodilla, Enrique; Galvañ, Vicente Giner; Izuel, J.M. Pascual; Catalá, Maria Teresa Climent; Alegre, Manuel; Franco, Salvador Alcázar; Garre, C. Alonso; Cercós, Cristina Aparicio; Fernández, Vicente Baixauli; Monzó, Otón Bellver; Congost, Marieta Cano; Catalá, Mª Teresa Climent; Molina, Vicente Colomer; Ferrándiz, Ma Edelmira Córcoles; Botella, MA Josefa Cortés; Correa, Francisco Delgado; Alonso, Daniel Dols; Estrela, Fernando Ferrer; Zaragozá, MA Eugenia García; Vidal, Lina Granell; Marrero, María Rosario Hernández; Mascarós, Antonio Herrero; Fibla, Enrique; Requena, Rafael Jordá; Requena, Adelia Jordá; Miró, Teresa Llopis; Martínez, Consuelo González; Castelló, Fernando Mud; Clérigues, Andres Navarro; Torregrosa, Zeneida Perseguer; Mas, Rosa Maria Prats; Soriano, María José Rodrigo; Gonzalez, Desirée Ruiz; Ibáñez, Luis Salar; Boronat, Maria Josep Sanchis; Donatg, Begoña Urcullu

doi:10.1016/j.medcli.2017.04.037

Cited by 10 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It will thereby be guaranteed that the totality of pharmacies will have access to learn about the conditions and the protocol to voluntarily participate in the project. About 32 pharmacies, all of them members of SEFAC, out of 2301 community pharmacies (1.4%) in the Valencia Community, participated in the pilot study RIVALFAR (Estudio epidemiológico para cuantificar la prevalencia de hipertensión arterial y RIgidez arterial en las FARmacias Comunitarias de la Comunidad VALenciana), representing 9.1% of the 350 pharmacies ascribed to SEFAC [43]. Calculating a similar level of engagement in the whole territory, the number of recruited pharmacies would reach approx.…”

Section: Pharmaciesmentioning

confidence: 99%

See 1 more Smart Citation

Assessment of Arterial Stiffness by Brachial Oscillometry in Community Pharmacies for Managing Hypertension (COPHARTEN)

Rodilla¹,

Prats²,

Bellver³

et al. 2019

Artery Res

View full text Add to dashboard Cite

Cardiovascular (CV) diseases remain the main cause of death in Spain and Western Europe with rapidly increasing incidence in Latin America. Hypertension (HTN) is the most important determinant of CV death. It firstly became 2016 the most prevalent chronic disease in Spain with 18.5% of the whole population affected, overtaking chronic back pain [1]. According to recent estimations, approximately 12 million subjects suffer HTN in Spain, but only 7 million Spaniards are aware of, less than half of them are treated, and only 2.5 millions thereof are adequately controlled. These numbers are equivalent to 9.5 million people with uncontrolled HTN in Spain, translating into an estimate of 100 CV deaths daily [2].

show abstract

Section: Pharmaciesmentioning

confidence: 99%

“…The RIVALFAR-study [43] contains the real world data on which our calculations for the sample size are based. The proportion of participants with normal blood pressure and no antihypertensive treatment was 58%.…”

Section: Sample Sizementioning

confidence: 99%